Inventor · disambiguated record
Jiajian Liu
Also filed as: LIU JIAJIAN
12 granted patents·7 pending applications·24 citations·filing 2008–2019
87Inventor score
Files withDAVIS JANET5JANSSEN BIOTECH INC5Shanghai hengrui pharmaceutical co ltd3JIANGSU HENGRUI MEDICINE CO2L&L BIOPHARMA CO LTD2
Top patents by PatentIndex Score
19 records- 0187US10543284B2Anti-c-Met antibody and anti-c-Met antibody-cytotoxic drug conjugate and pharmaceutical use thereofSUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD·Filed 2016·Granted Jan 28, 2020·6 cites·36 claims
- 0282US11912763B2Antibody targeting CLDN18.2, bispecific antibody, ADC, and CAR, and applications thereofL&L BIOPHARMA CO LTD·Filed 2019·Granted Feb 27, 2024·4 cites·20 claims
- 0382US9593306B2Differentiation of pluripotent stem cellsDAVIS JANET·Filed 2012·Granted Mar 14, 2017·3 cites·13 claims
- 0480US8623648B2Treatment of pluripotent cellsDAVIS JANET·Filed 2008·Granted Jan 7, 2014·3 cites·11 claims
- 0579US10449250B2Anti-sclerostin antibody, antigen binding fragment and medical use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2016·Granted Oct 22, 2019·2 cites·20 claims
- 0679US9593305B2Differentiation of pluripotent stem cellsDAVIS JANET·Filed 2012·Granted Mar 14, 2017·2 cites·22 claims
- 0775US9845460B2Treatment of pluripotent cellsJANSSEN BIOTECH INC·Filed 2013·Granted Dec 19, 2017·1 cites·9 claims
- 0873US9862765B2IL-17A binding agent and uses thereofShanghai hengrui pharmaceutical co ltd·Filed 2014·Granted Jan 9, 2018·2 cites·25 claims
- 0965US2010015711A1Differentiation of Pluripotent Stem CellsDAVIS JANET·Filed 2009·Application pending·0 cites
- 1063US10351820B2Methods for making definitive endoderm using at least GDF-8JANSSEN BIOTECH INC·Filed 2017·Granted Jul 16, 2019·0 cites·19 claims
- 1163US10233421B2Differentiation of pluripotent stem cellsJANSSEN BIOTECH INC·Filed 2017·Granted Mar 19, 2019·0 cites·14 claims
- 1259US2018127723A1Treatment of pluripotent cellsJANSSEN BIOTECH INC·Filed 2017·Application pending·0 cites
- 1352US2011091971A1Differentiation of Pluripotent Stem CellsDAVIS JANET·Filed 2009·Application pending·0 cites
- 1450US10050552B2High-frequency isolation alternating/direct current conversion circuit and control method thereofSHENZHEN BOYN ELECTRIC CO LTD·Filed 2017·Granted Aug 14, 2018·1 cites·9 claims
- 1545US2016326230A1Human relaxin analogue, pharmaceutical composition of same, and pharmaceutical application of sameShanghai hengrui pharmaceutical co ltd·Filed 2014·Application pending·0 cites
- 1644US2013337564A1Treatment of Pluripotent CellsJANSSEN BIOTECH INC·Filed 2013·Application pending·0 cites
- 1740US9458219B2Human insulin analogue and acylated derivative thereofShanghai hengrui pharmaceutical co ltd·Filed 2012·Granted Oct 4, 2016·0 cites·23 claims
- 1840US2021269521A1Bispecific antibody and use thereofL&L BIOPHARMA CO LTD·Filed 2019·Application pending·0 cites
- 1937US2019315886A1Thrombin antibody, antigen-binding fragment and pharmaceutical use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jiajian Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →